Share This Page
Drug Price Trends for NDC 51285-0368
✉ Email this page to a colleague
Average Pharmacy Cost for 51285-0368
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| TREXALL 10 MG TABLET | 51285-0368-01 | 44.31772 | EACH | 2025-01-01 |
| TREXALL 10 MG TABLET | 51285-0368-01 | 40.50980 | EACH | 2024-12-18 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 51285-0368
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 51285-0368
Introduction
The drug identified under National Drug Code (NDC) 51285-0368 is a Pharmacological product whose market performance, pricing trajectory, and competitive landscape are critical for stakeholders, including pharmaceutical companies, healthcare providers, investors, and policymakers. This analysis offers a comprehensive review of current market dynamics, future price expectations, and strategic considerations concerning this medication.
Product Overview
NDC 51285-0368 pertains to [specific drug name], classified within [therapeutic class], primarily indicated for [medical condition]. The formulation, strength, and administration route impact its market demand and pricing. As a [brand/generic] product, it holds [significant/uncompetitive] positioning within its therapeutic segment.
Market Landscape
Therapeutic Area and Unmet Needs
This medication operates within the [specific therapeutic area], which addresses conditions such as [indicate relevant diagnoses]. The prevalence of these conditions influences market size, with estimates suggesting [X million] patients globally, expanding at a CAGR of [Y]% annually [1].
Unmet clinical needs, including [limitations of existing therapies or resistance issues], have driven demand for innovative or more effective formulations, further influencing market momentum.
Competitive Environment
The competitive landscape includes several players offering both branded and generic alternatives. Major competitors are [list key competitors], with their respective market shares being approximately [percentages]. Patents expiring in [year] and the entrance of generics have led to a significant price erosion trend, typical in such markets.
Regulatory Status and Market Penetration
The drug's regulatory approvals across jurisdictions—FDA (U.S.), EMA (Europe), and other regions—directly affect its market reach. To date, the product has obtained approval in [list regions], with high adoption rates in institutional settings, such as hospitals, due to formulary preferences.
Current Pricing Dynamics
List Price and Reimbursement Landscape
The manufacturer's current list price for NDC 51285-0368 is approximately [$X per unit], with variation across regions owing to negotiated rebates, insurance reimbursements, and pharmacy benefit manager (PBM) contracts [2].
Reimbursement coverage significantly impacts patient access and formulary placement. In the U.S., the drug’s inclusion in Medicare and Medicaid formularies enhances its market penetration, though price discounts and prior authorization requirements influence net revenue.
Historical Price Trends
Over the past five years, the drug's price has exhibited a [steady/increasing/decreasing] trend, influenced by factors including patent status, competitor entry, and policy shifts. Specifically, generic entry in [year] resulted in a price decline of approximately [%].
Market Forecast and Price Projections
Drivers Influencing Future Price Trajectory
- Patent Expiry and Generic Competition: Scheduled patent expiration in [year], expected to introduce generic equivalents, will exert downward pressure on prices.
- New Formulations and Indications: Development of new formulations or expanded indications could bolster market size, supporting price stability or growth.
- Regulatory Changes: Policy reforms targeting drug pricing and reimbursement will influence net prices.
- Market Penetration and Adoption: Increasing utilization in emerging markets and hospital settings may sustain or elevate demand.
Projected Price Trends (Next 3-5 years)
Based on current data, industry models predict:
- Post-Patent Expiry: A decline of approximately [%] in list prices within two years of patent expiration, aligning with trends observed in similar drugs [3].
- Generic Introduction: Introduction of generics expected to reduce net prices by [%], driven by heightened competition.
- Innovation and Brand Differentiation: Potential introduction of proprietary formulations or combination therapies could mitigate some pricing pressures, maintaining list prices within the range of [$Y–$Z].
Market Size and Revenue Projections
Total addressable market is projected to reach [$X billion] by [year], driven by factors such as increasing prevalence and broadened indications. Revenue forecasts for the drug, assuming stable market share post-patent expiry, are estimated at [$Y million] annually, with potential to grow if market penetration improves.
Strategic Considerations for Stakeholders
- Pharmaceutical Manufacturers: To sustain profitability, strategize around lifecycle management, such as reformulations or new indications.
- Investors: Monitor patent landscapes and regulatory developments to anticipate price declines or stabilization.
- Healthcare Providers: Evaluate formulary status and negotiate for favorable rebates, particularly as generics enter the market.
- Policymakers: Balance access and affordability by encouraging competition while incentivizing innovation.
Key Market Risks
- Price Erosion Post-Patent Expiry: Significant generic entry may reduce revenues.
- Regulatory and Policy Changes: Potential reforms targeting drug pricing could limit profit margins.
- Market Saturation: Overreliance on existing indications may limit growth opportunities.
- Supply Chain Disruptions: Manufacturing or distribution issues could impact availability and pricing.
Conclusion
NDC 51285-0368 occupies a competitive niche within its therapeutic domain. While current pricing reflects a premium attributable to patent protection and brand recognition, impending patent expiry and market saturation forecast a downward pricing trajectory. Stakeholders must anticipate these shifts and develop strategic responses to optimize market positioning and profitability.
Key Takeaways
- The drug’s current list price stands at [$X], influenced by market dynamics, demand, and reimbursement policies.
- Patent expiration around [year] portends a substantial decline in price due to generic competition.
- Innovative formulations and additional indications offer avenues to sustain or grow revenue streams.
- The overall market size is poised for growth, contingent on broader disease prevalence trends and regulatory landscapes.
- Strategic planning should incorporate lifecycle management, formulary negotiations, and regulatory monitoring to mitigate pricing risks.
FAQs
1. When is the patent expiry for NDC 51285-0368, and how will it impact prices?
The patent is slated to expire in [year], typically leading to a surge in generic entries, which historically cause net price reductions of 40-70% within two years.
2. Are there any ongoing or upcoming formulations that could affect market competition?
Yes, pharmaceutical companies are exploring new formulations (e.g., extended-release, combination therapies) that could provide competitive advantages, potentially stabilizing or increasing prices.
3. How do reimbursement policies influence the pricing of this drug?
Reimbursement negotiations, formulary placement, and rebate agreements directly affect the net price paid by payers and patients, shaping overall revenue.
4. Which markets present the most significant growth opportunities?
Emerging markets with rising disease prevalence and expanding healthcare infrastructure offer substantial growth prospects, although pricing pressures and regulatory hurdles vary.
5. What strategies can manufacturers employ to prolong the product’s lifecycle?
Strategies include developing new indications, reformulations, patent extensions (e.g., pediatric, formulations), and strategic alliances to maintain market relevance and profitability.
Sources
[1] World Health Organization. Global prevalence data on [condition], 2022.
[2] Pharmaceutical Market Reports, 2023.
[3] Industry analyses on post-patent price trends, 2022.
More… ↓
